Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Charlotte Sale joins Page & Page and Partners as senior account director

Sale has worked for major pharma and dental manufacturers for over 14 years

- PMLiVE

Mapping the patient journey: eight ways to improve support programmes

Chris Ross examines how pharma can drive awareness and adoption of patient support solutions

- PMLiVE

Yescarta gains first FDA approval for indolent follicular lymphoma

First CAR-T cell therapy to be approved in this indication

- PMLiVE

WHITE PAPER: What’s missing in women’s health?

In July of last year, amidst stories in the press around HRT and contraception shortages, endometriosis going undiagnosed and unsafe medical devices being offered to women, we wrote an edition...

IGNIFI

- PMLiVE

Pfizer/BioNTech’s COVID-19 vaccine neutralises Brazil variant, suggests study

Neutralisation of variant 'roughly equivalent' to original SARS-CoV-2 strain

- PMLiVE

Lilly partners with Biolojic Design to develop diabetes antibody therapies

Agreement could be worth up to $121m in milestone payments

IWD2021: #ChooseToChallenge Interview with Dennis O’Brien, Lucid Group CEO

Hey Dennis, what does this year’s IWD slogan, #ChooseToChallenge mean to you?I love it. It’s inspirational and action-oriented. It’s clear we need to change many things in our society, inequality...

Lucid Group Communications Limited

- PMLiVE

EMA recommends use of Lilly’s COVID-19 antibody cocktail

Agency concludes bamlanivimab and etesevimab can be used to treat certain COVID-19 patients

- PMLiVE

Novartis and NHS England reach ‘landmark’ deal for Zolgensma gene therapy for SMA

Children born with SMA type 1 typically have a life expectancy of around two years

- PMLiVE

Merck & Co, Ridgeback Biotherapeutics’ COVID-19 drug shows early promise

Molnupiravir led to a faster decrease in infectious virus among participants with early COVID-19

- PMLiVE

GCI Health opens new office in Brussels

Move expands agency's global public affairs offering

- PMLiVE

Lilly’s tirzepatide shows superiority over Novo’s semaglutide in type 2 diabetes trial

Lilly's drug beat semaglutide 1mg on multiple measures including weight loss

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links